GlassScriptPhysician profile
Amanda Lynn Hill
NPI 1518485614
$1,173.49
in general payments reported to CMS, 2019-2025
14 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $88.48 · 2022: $548 · 2023: $189 · 2024: $180 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $536.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $216.40 | 2021-2024 | Phexxi |
| Dilon Technologies, INC. | $142.83 | 2025 | Hemoblast Bellows |
| Myovant Sciences INC. | $141.89 | 2021-2022 | |
| Astellas Pharma US INC | $120.93 | 2024 | Veozah |
| Sage Therapeutics, LLC | $118.36 | 2023 | |
| Phadia US INC. | $111.60 | 2022 | |
| Nevro Corp. | $98.50 | 2022 | |
| Gilead Sciences, INC. | $98.49 | 2022 | |
| Pfizer INC. | $28.64 | 2022-2023 | |
| Orphalan INC | $24.86 | 2025 | Cuvrior |
| Asensus Surgical, INC. | $19.78 | 2021 | |
| Exeltis, USA INC. | $19.70 | 2022 | |
| Philips North America LLC | $18.35 | 2024 | (Br5) Peripheral Ivus |
| Mayne Pharma Commercial LLC | $13.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.